Patents by Inventor David Peritt

David Peritt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050002937
    Abstract: The present invention relates to at least one novel anti-IL-12 antibodies, including isolated nucleic acids that encode at least one anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: August 6, 2004
    Publication date: January 6, 2005
    Inventors: Jill Giles-Komar, David Knight, David Peritt, Bernard Scallon, David Shealy
  • Publication number: 20030166303
    Abstract: The present invention relates to a robust and sensitive assay system utilizing synthetic spherical structures in place of cells for a FACS analysis. The method and system detects the affinity and neutralization activity of a biological molecule without interference from growth medium or cell supernatants. The systems associated with these methods allow high-throughput screening of assays for, in particular, neutralizing monoclonal antibodies.
    Type: Application
    Filed: December 18, 2002
    Publication date: September 4, 2003
    Inventors: David Peritt, Jonathan H. Seideman
  • Publication number: 20030157105
    Abstract: The present invention relates to at least one novel anti-p40 immunoglobulin (Ig) derived protein, including isolated nucleic acids that encode at least one anti-p40 Ig derived protein, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: May 28, 2002
    Publication date: August 21, 2003
    Inventors: Jill M. Carton, David Peritt
  • Publication number: 20030124123
    Abstract: The present invention relates to at least one novel anti-IL-12 antibodies, including isolated nucleic acids that encode at least one anti-IL-12 antibody, IL-12, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: August 1, 2001
    Publication date: July 3, 2003
    Inventors: Jill Giles-Komar, David M. Knight, David Peritt, Bernard Scallon, David Shealy